Menu
Recruiting NCT07027930

A Feasibility Trial of Eye Movement Desensitization and Reprocessing Therapy- Integrative Treatment Group Protocol for Ongoing Traumatic Stress In Road Traffic Accident Survivors for Reduction of Post-traumatic Stress Symptoms

No phase Interventional Post Traumatic Stress Symptoms Quality of Life (QOL) Stress

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Eye movement desensitization and reprocessing therapy integrative group treatment protocol for Ongoing traumatic stress.
Who it may be relevant to
Registry conditions: Post Traumatic Stress Symptoms, Quality of Life (QOL), Stress. Basic parameters: 18 years — 45 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Pakistan
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

A Feasibility Trial of Eye Movement Desensitization and Reprocessing Therapy- Integrative Treatment Group Protocol for Ongoing Traumatic Stress in Road Traffic Accident Survivors for Reduction of Post-Traumatic Stress Symptoms

Overview

Road traffic accidents (RTAs) are a significant public health concern globally, accounting for a substantial proportion of morbidity and mortality. This study evaluates the feasibility and acceptability of the Eye Movement Desensitization and Reprocessing Integrative Group Treatment Protocol for Ongoing Traumatic Stress (EMDR-IGTP-OTS) in the reduction of posttraumatic stress symptoms, depression, and anxiety, while improving the quality of life in individuals who have experienced traffic accidents. Using a randomized control design, participants aged 18-45 will be assessed at three-time points: pre-treatment, post-treatment, and one-month follow-up. The study employs the DASS-21, UIES-R, and WHOQOL-BREF as evaluation measures. Findings aim to expand evidence on trauma-focused interventions and explore their applicability in culturally diverse, resource-constrained settings.

Interventions

  • Other Eye movement desensitization and reprocessing therapy integrative group treatment protocol for Ongoing traumatic stress
    EMDR-IGTP-OTS is a group intervention based on EMDR 8-phased protocols with the integration of the Butterfly hug technique.

Primary outcome measures

  • The Urdu Impact of Event Scale-Revised [Time frame: From Enrollment to end of study after 4 weeks]

Eligibility criteria

Inclusion criteria

  • Aged between 18 and 45 years.
  • Experienced a traffic accident 3 months to 10 years prior
  • Willing to participate and able to understand the intervention components.

Exclusion criteria

  • Participants will be excluded from the study if they meet any of the following criteria:
  • Diagnosed with conditions such as schizophrenia or bipolar disorder, which require specialized treatment beyond the scope of this study.
  • History of severe head injuries resulting in neurological or cognitive deficits.
  • Participants who have experienced a traffic accident less than 3 months ago, as immediate post-traumatic responses may not have stabilized

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Health services research

Study locations

Pakistan · 1 center
  • Public Universities — Lahore

Publications

  • Yasar AB, Konuk E, Kavakci O, Uygun E, Gundogmus I, Taygar AS, Uludag E. A Randomized-Controlled Trial of EMDR Flash Technique on Traumatic Symptoms, Depression, Anxiety, Stress, and Life of Quality With Individuals Who Have Experienced a Traffic Accident. Front Psychol. 2022 Mar 24;13:845481. doi: 10.3389/fpsyg.2022.845481. eCollection 2022. PMID 35401305

Identifiers

NCT: NCT07027930 · IGTP-OTS-MSCCP-2022

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗